Fed. Circ. Denies Becton $1.9M Extra Fees In TheraSense Row

Law360, New York (March 12, 2014, 4:31 PM EDT) -- A split Federal Circuit on Wednesday refused to order Abbott Laboratories to fork over $1.9 million in additional attorneys' fees to Becton Dickinson & Co. and Nova Biomedical Corp. in the companies' long-running case over Abbott's blood glucose-testing patents.

Back in 2009, Becton and Nova won just under $6 million in fees back after a district court ruling that they hadn't infringed Abbott's testing technology, but that was followed by more than two years of appeals from Abbott. When Becton and Nova finally prevailed once more,...
To view the full article, register now.